Similar articles

• [Comparative study of pirenzepine and ranitidine in the prevention of stress ulcer in patients in intensive care].

  Testasecca D, Sestili R, Valentini P, Pennacchioni S, Ventrella S, Torroni P, Tjia AT, Legeza G. Testasecca D, et al. Clin Ter. 1986 Jan 15;116(1):25-30. Clin Ter. 1986. PMID: 3754501 Italian. No abstract available.
• [Prevention of gastroduodenal stress lesions with secretion inhibitors in accident patients needing intensive care: incidence of lesions and adverse effects; consequences].

  Barandun J, Leutenegger A, Frutiger A, Rüedi T, Kobler E. Barandun J, et al. Schweiz Med Wochenschr. 1985 Jul 20;115(29):1022-3. Schweiz Med Wochenschr. 1985. PMID: 3840276 Clinical Trial. German.
• [Use of pirenzepine in prevention of stress ulcers in high-risk surgical patients].

  Butti A, De Giovanni L, Reggio D, Valentini P, Civello IM. Butti A, et al. Minerva Med. 1986 May 12;77(20):867-72. Minerva Med. 1986. PMID: 3523298 Clinical Trial. Italian.
• [Acid reducing drugs for prevention of stress ulcer: cause for the development of nosocomial pneumonia? Arguments pro].

  Tryba M. Tryba M. Z Gastroenterol. 1991 Jan;29 Suppl 1:32-40; discussion 43. Z Gastroenterol. 1991. PMID: 1962499 Review. German. No abstract available.
• Pirenzepine in the treatment of peptic ulcer disease. Review and commentary.

  Bianchi Porro G, Petrillo M. Bianchi Porro G, et al. Scand J Gastroenterol Suppl. 1982;72:229-36. Scand J Gastroenterol Suppl. 1982. PMID: 6753117 Review.